Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 3 1Phase 2/3 1Phase 1 1

Status

Terminated 3Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4Thoracic 2Other hematologic neoplasm 1Head & Neck 1Gastrointestinal 1

Conditions

Breast Neoplasms 3Parasomnias 1Depression 1Breast Cancer - Female 1Anxiety Disorders 1

Interventions

Trastuzumab 260Paclitaxel 216Cyclophosphamide 173Docetaxel 146Letrozole 126Fulvestrant 121Capecitabine 121Doxorubicin 111Carboplatin 98Bevacizumab 90exemestane 88Anastrozole 85Tamoxifen 77Lapatinib 77pembrolizumab 68Albumin-Bound Paclitaxel 67pertuzumab 62palbociclib 60Taxes 59Gemcitabine 57eribulin 48130-nm albumin-bound paclitaxel 47Radiotherapy 46Everolimus 44Ado-Trastuzumab Emtansine 43Vinorelbine 39ixabepilone 32Epirubicin 30Cisplatin 30pegfilgrastim 29

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Has results × Melatonin × Breast × Clear all
NCT02332928 2023-03-30

Melatonin Supplementation for Cancer-related Fatigue in Patients Receiving Radiotherapy

Virginia Commonwealth University

Phase 3 Terminated
80 enrolled 15 charts
Breast

Breast Cancer - Female

NCT01805089 2015-03-23

Melatonin Versus Placebo in Breast Cancer

Dana-Farber Cancer Institute

Phase EARLY_PHASE1 Completed
95 enrolled 14 charts
Breast

Breast Neoplasms

NCT01355523 2014-05-06

MELODY

Herlev Hospital

Phase 2/3 Terminated
54 enrolled 27 charts
Breast

Anxiety Disorders, Breast Neoplasms, Depression, Parasomnias

NCT00506064 2012-12-05

Melatonin Postoperative Sleep Study in Breast Cancer Patients

M.D. Anderson Cancer Center

Phase 1 Terminated
4 enrolled 2 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡